CO2 Laser-Assisted Sclerectomy Shows Feasibility in Small Uveal Effusion Syndrome Series

A prospective descriptive case series evaluated CO2 laser-assisted sclerectomy surgery (CLASS) with sclerostomy in three eyes of three patients with idiopathic uveal effusion syndrome (UES) and exudative retinal detachment. The primary aim was to assess the feasibility and early outcomes of the technique.

The main results showed sustained improvement of retinal detachment in all three patients (3/3). Complete resolution of the retinal detachment was achieved in two of the three cases (2/3). Patients were followed for a mean of 410 days (range, 34 to 825 days). No adverse events were observed during the follow-up period.

Key limitations of this evidence include the very small sample size of only three patients, which is explicitly noted by the authors. They state that further studies are warranted to confirm these findings. The study design, a descriptive case series, provides only preliminary evidence of feasibility and cannot establish efficacy or compare outcomes to other treatments.

For clinical practice, this report provides an early, positive signal for a surgical technique in a rare and challenging condition. The absence of observed adverse events in this tiny cohort is encouraging but not definitive for safety. Clinicians should interpret these findings as a preliminary technical note, not as evidence supporting a change in practice. Management decisions should continue to rely on established evidence until more robust data are available.